
Globally, 10 million new cases every year and people die every day due to Tuberculosis (TB). TB is curable if detected at early stages and treated with correct antibiotics. If not, the TB bacteria develops resistance and becomes a challenge for diagnosis and treatment. Rapid and accurate detection of multi-drug resistant (MDR) strains is urgently needed to effectively treat patients and prevent spreading of drug-resistant TB in the community. EMPE Diagnostics AB, Sweden has developed mfloDx® technology that can rapidly detect the TB causing bacteria and its drug-resistance profiles in less…
Annual Revenue$10M to $25MBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more

Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.